Shares of Compass Inc. turned higher after a Wall Street Journal report that the real-estate brokerage is in talks to buy ...

Compass posted strong growth in its fourth-quarter ... According to data from S&P Global Market Intelligence, the stock was up 15% for the week as of Friday at 2:14 p.m. ET. Revenue soared 25.9 ...

Shares of Compass Therapeutics (NASDAQ:CMPX) were up 8% in afternoon trading Monday after Guggenheim initiated coverage of the stock with a buy rating ahead of upcoming data for the company's drug ...

According to data from S&P Global Market Intelligence, the stock was up 15% for the week as of Friday at 2:14 p.m. ET. Image source: Compass. Revenue soared 25.9% in Q4 to $1.38 billion ...

If Compass can reach GAAP profitability, it could have a lot of upside. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now ...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Compass Diversified (NYSE:CODI), it sends a favourable ...

Shares of NYSE COMP opened at $9.76 on Wednesday. The stock has a 50 day moving average price of $6.76 and a 200 day moving average price of $6.23. Compass has a 52 week low of $2.89 and a 52 week ...

But moves this big are rare even for Compass and indicate this news significantly impacted the market’s perception of the business. The biggest move we wrote about over the last year was 10 months ago ...

Barclays currently has an equal weight rating on the stock. Several other equities analysts have also issued reports on COMP. The Goldman Sachs Group boosted their price target on Compass from $8. ...

Investing.com -- Shares of Compass Inc (NYSE: COMP) soared 24% after the company reported stronger-than-expected revenue for the fourth quarter, signaling robust growth despite a challenging real ...